Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. - Wikidata - wikimedia - TriplyDB

Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.

Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.

http://www.wikidata.org/entity/Q46386533

about

Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53 Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism Potential Roles of Adropin in Central Nervous System: Review of Current Literature Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease The associations between Parkinson's disease and cancer: the plot thickens The neurology of mTOR Erythropoietin: new directions for the nervous system Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders Driving neural regeneration through the mammalian target of rapamycin Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease.Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation The role of mTOR signaling in Alzheimer disease NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway.The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc.Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia.Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.Why pleiotropic interventions are needed for Alzheimer's disease.Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease.Honey bee PTEN--description, developmental knockdown, and tissue-specific expression of splice-variants correlated with alternative social phenotypes.Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits.A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity.Genetic determinants at the interface of cancer and neurodegenerative disease.Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Taking aim at Alzheimer's disease through the mammalian target of rapamycin Amyloid-β as a modulator of synaptic plasticity Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau.Fragile X mental retardation protein: from autism to neurodegenerative disease.Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Ceramides as modulators of cellular and whole-body metabolism

P2860

Q21560776-F56B61B4-D598-423F-854E-3D029E7E6417 Q24303650-8A6B3651-57C3-4716-9B41-E0B68F3E7310 Q24595310-3B7B8840-A8B9-4EFF-B732-BB0F08F0486A Q26742073-FEC83BEC-4DA6-4D96-BAE8-FDB14EB76F86 Q26773657-8DE0971C-8407-4F1D-8074-92A47EB47139 Q26778641-5EA359C1-40A5-497F-8418-7B23EDBADB54 Q26824286-B0788D18-A974-4F05-A7C3-20BA53062625 Q26828425-5B9A5C5E-C7F4-4074-A36D-5845FEF9B835 Q27015640-31412B56-DE6C-4A27-974F-3CD01325B1E8 Q27022790-B3A32B2E-D0BA-416C-B6D6-97633C59312F Q27027516-50F0AF69-9541-45AD-87B0-5B0849B9A17B Q27864126-7B0442DD-1190-4A4D-9211-E4D8D6680311 Q28087030-21E8C344-955B-4507-8659-F006AB763F14 Q28256247-080B7CD1-6F98-42BA-81BA-11CBE8ADB919 Q28384823-259296A0-9E9F-4CCD-A48B-392A21B5F787 Q30485596-24150C08-B2D5-4C7D-930F-D69A9513BCB4 Q30539812-9F54D2E0-D188-44D0-A667-21B5D8B5C2B9 Q33553429-91BB0CB1-257D-43D3-AE41-10037F9F9640 Q33600053-DF6681DA-FCD4-42A7-888B-C91B57371076 Q33707896-38552797-0EAD-4EDF-A244-9E2E08489182 Q33744696-885B9E24-CB42-4325-9144-B93118F1FDA8 Q33757441-47711F22-EF31-4207-B51A-779604E12B2C Q33769079-CDC8985E-E400-4C38-9D1D-8F9D934EC6FA Q33775384-4A8A96E4-54B0-4443-A09A-F58627D8EAD6 Q33876128-0E2FAFB8-950A-48FA-BC8E-70DD9D090B23 Q33887259-6B592B41-7F51-4A24-92F6-125AFCD6B36D Q33914286-A5A234ED-EE4C-44F7-8379-09E9CBEAB237 Q33968299-796C6A33-6FA6-4C0C-84FC-6AF0D7675288 Q34043165-7026140C-758C-43CF-8683-5E10CA8E4793 Q34073879-F5A75E4B-7C4B-426B-8A0A-D96F0C939A8C Q34077007-BBA6B129-29ED-4382-B5FC-04D0A7081C9D Q34422582-F347EE25-F0C7-4DC6-A222-C58E08398BE3 Q34429308-29E70D62-ABFE-423B-AE9D-6E75A9D34301 Q34603651-90A86D6B-2612-48B8-A213-DBC5FA2F8873 Q34814145-57D3851C-259C-450D-8D53-E87A7D55470A Q35016068-81F148C8-88D3-4898-89BE-98C2CF58511D Q35077291-E696E253-3ABA-4270-8BB6-2FCA36235E73 Q35126030-0DDC3D7F-0EB5-449C-9594-2FD199983E57 Q35157985-A4003011-EB2B-4706-853A-01ED4D53BED0 Q35484864-31216320-E5E9-480A-908A-FAB04968E125

P2860

Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.

http://www.wikidata.org/entity/Q46386533

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@en

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@nl

type

label

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@en

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@nl

prefLabel

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@en

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@nl

P1433

Q46386533-A3708067-620D-44D1-A862-F5F23C6EDC97

P1476

Q46386533-5958D6DF-7966-4B82-B8AC-9E58D6BED7C8

P2093

Q46386533-5AE8ABA3-724C-48F1-AE3B-A42062B10ED9

Q46386533-6392D1D2-30A6-4EA8-B8CD-9467FC18B3BE

Q46386533-7EC0279F-A5B4-4EDA-AD80-6B36097C7387

Q46386533-98E6B42D-E6FA-4E41-A57D-1F55B311C78E

Q46386533-AD491921-AE06-4A98-BCC9-6FFAC75A1D95

Q46386533-C3348916-0634-445A-B86A-755703BA234F

Q46386533-C7933708-2A4F-4F55-AB84-4513E8155292

Q46386533-FD9010CD-C75B-4841-9FD6-751059805879

P304

Q46386533-56C93815-592A-47EC-BEAA-9767E5543354

P31

Q46386533-F6BAAF67-98B8-4685-8E31-7FCE143E24B4

P356

Q46386533-2C43E6A3-13C8-43AE-A4B8-A23337A6E62B

P407

Q46386533-82356F87-9854-446B-BE53-B6E0420C2556

P433

Q46386533-DD85654A-D601-418D-B7D3-A3140D446DA8

P478

Q46386533-D8534267-795A-4339-BCDB-F55C3AD1CFC1

P577

Q46386533-D043611F-2F7E-4F54-8AE8-DE67761281F7

P5875

Q46386533-99F414F3-C009-42BA-946B-9BE3EEC2C1D0

P698

Q46386533-BCC7A33E-B852-4978-ACF6-D32DE97C45A7

P921

Q46386533-39815979-17EC-461F-AED8-AFFA2B303887

Q46386533-398F2DEB-C812-4B7F-BAC1-F8B9CDE568BF

Q46386533-6cf6a773-b8d4-410f-bbfb-8e67c2c3f2c1

P356

J.1471-4159.2004.02949.X

P1433

Journal of Neurochemistry

P1476

Activation of Akt/PKB, increas ...... Alzheimer's disease pathology.

@en

P2093

Aileen Moloney

http://www.w3.org/2001/XMLSchema#string

Cora O'Neill

http://www.w3.org/2001/XMLSchema#string

Janet A Johnston

http://www.w3.org/2001/XMLSchema#string

Mary Kelliher

http://www.w3.org/2001/XMLSchema#string

Peter Dockery

http://www.w3.org/2001/XMLSchema#string

Rebecca J Griffin

http://www.w3.org/2001/XMLSchema#string

Rivka Ravid

http://www.w3.org/2001/XMLSchema#string

Rosemary O'Connor

http://www.w3.org/2001/XMLSchema#string

P304

105-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1471-4159.2004.02949.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7960879

http://www.w3.org/2001/XMLSchema#string

P698

15773910

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

phosphorylation